Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis

Rheumatology

Volumn 41, Issue 4, 2002, Pages 458-461

  Knijff Dutmer, E A J ^a   Kalsbeek Batenburg, E M ^a   Koerts, J ^a   Van De Laar, M A F J ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Bleeding time; Meloxicam; Naproxen; Non steroidal anti inflammatory drugs; Platelet aggregation; Rheumatoid arthritis; Thromboxane

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOGLUCOSE; AZATHIOPRINE; CYCLOOXYGENASE 2 INHIBITOR; HYDROXYCHLOROQUINE; MELOXICAM; METHOTREXATE; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PROTHROMBIN; SALAZOSULFAPYRIDINE; STEROID; THROMBOPLASTIN; THROMBOXANE;

ADULT; ARTICLE; BLEEDING TIME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EXPOSURE; DRUG SELECTIVITY; FEMALE; HUMAN; INHIBITION KINETICS; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; BLEEDING TIME; BLOOD PLATELETS; CROSS-OVER STUDIES; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; NAPROXEN; PLATELET AGGREGATION; RANDOM ALLOCATION; THIAZINES; THIAZOLES; THROMBOXANE B2;

EID: 0036100771     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
2. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes
3. New insights into the mode of action of anti-inflammatory drugs
4. COX-2 inhibitors
5. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis
6. Effect of nabumetone (BRL 14777), a new anti-inflammatory drug, on human platelet reactivity ex vivo: Comparison with naproxen
7. Effects of meloxicam and indomethacin on cyclo-oxygenase pathways in healthy volunteers
8. The effect of nabumetone versus naproxen on platelet aggregation in patients with rheumatoid arthritis
9. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
10. Prediction of creatinine clearance from serum creatinine
11. The standardisation of certain factors in the cutaneous 'venostasis' bleeding time technique
12. Aggregation of blood platelets by adenosine and its reversal
13. Risk of cardiovascular events associated with COX-2 inhibitors
14. Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases
15. Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers
16. A study of the platelet effects of SC-58635, a novel COX-2-selective inhibitor
17. The effect of nabumetone and its principal metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function
18. Meloxicam, 15 mg/day, spares platelet function in healthy volunteers
19. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomized, controlled trial